Didymin, a dietary flavonoid glycoside from citrus fruits, induces Fas-mediated apoptotic pathway in human non-small-cell lung cancer cells in vitro and in vivo

Lung Cancer

Volumn 68, Issue 3, 2010, Pages 366-374

  Hung, Jen Yu ^a,b,c   Hsu, Ya Ling ^a   Ko, Ying Chin ^a,d   Tsai, Ying Ming ^c   Yang, Chih Jen ^b,c   Huang, Ming Shyan ^a,b,c   Kuo, Po Lin ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Apoptosis; Didymin; Fas ligand; Fas APO 1; Non small cell lung cancer; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DIDYMIN; FAS ANTIGEN; FAS LIGAND; FLAVONOID GLYCOSIDE; PROTEIN P53; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FLAVONOID; GLYCOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CITRUS FRUIT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; CARCINOMA, NON-SMALL-CELL LUNG; CITRUS; DRUG EFFECTS; FRUIT; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CITRUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FAS LIGAND PROTEIN; FLAVONOIDS; FRUIT; GLYCOSIDES; HUMANS; LUNG NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952553455     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.08.013     Document Type: Article

References (39)

1. Gajra A., Newman N., Gamble G.P., Abraham N.Z., Kohman L.J., Graziano S.L. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 2003, 42:51-57.
2. McCracken M., Olsen M., Chen M.S., Jemal A., Thun M., Cokkinides V., et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007, 57:190-205.
3. Erridge S.C., Møller H., Price A., Brewster D. International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 2007, 4:570-577.
4. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002, 2:277-288.
5. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348.
6. Chang G.C., Yu C.T., Tsai C.H., Tsai J.R., Chen J.C., Wu C.C., et al. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells. Eur J Pharmacol 2008, 600:37-44.
7. Du A., Zhao B., Miao J., Yin D., Zhang S. Safrole oxide induces apoptosis by up-regulating Fas and FasL instead of integrin beta4 in A549 human lung cancer cells. Bioorg Med Chem 2006, 14:2438-2445.
8. Rho J.K., Choi Y.J., Ryoo B.Y., Na I.I., Yang S.H., Kim C.H., et al. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer. Cancer Res 2007, 67:1163-1169.
9. Shimizu M., Kondo M., Ito Y., Kume H., Suzuki R., Yamaki K. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Cancer Detect Prev 2005, 29:175-180.
10. Sun S.Y., Yue P., Hong W.K., Lotan R. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res 2000, 60:6537-6543.
11. Yoshimoto Y., Kawada M., Ikeda D., Ishizuka M. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo. Int Immunopharmacol 2005, 5:281-288.
12. Chopin V., Toillon R.A., Jouy N., Le Bourhis X. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol 2002, 135:79-86.
13. Nagata S., Golstein P. The Fas death factor. Science 2002, 267:1449-1456.
14. Juo P., Kuo C.J., Yuan J., Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998, 8:1001-1008.
15. Kim P.K., Park S.Y., Koty P.P., Hua Y., Luketich J.D., Billiar T.R. Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells. J Thorac Cardiovasc Surg 2003, 125:1336-1342.
16. Arts I.C. A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J Nutr 2008, 138:1561S-1566S.
17. Donaldson M.S. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004, 3:19.
18. Stoner G.D., Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 1995, 22:169-180.
19. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001, 21:381-406.
20. Aggarwal B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397-1421.
21. Ramos A.M., Aller P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem Pharmacol 2008, 75:1912-1923.
22. Calabrò M.L., Galtieri V., Cutroneo P., Tommasini S., Ficarra P., Ficarra R. Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice. J Pharm Biomed Anal 2004, 35:349-363.
23. Finotti E., Di Majo D. Influence of solvents on the antioxidant property of flavonoids. Nahrung 2003, 47:186-187.
24. Mouly P., Gaydou E.M., Auffray A. Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using liquid chromatography. J Chromatogr A 1998, 800:171-179.
25. Ross S.A., Ziska D.S., Zhao K., ElSohly M.A. Variance of common flavonoids by brand of grapefruit juice. Fitoterapia 2000, 71:154-161.
26. May P., May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999, 18:7621-7636.
27. Gu Y., Turck C.W., Morgan D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993, 366:707-710.
28. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
29. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704.
30. Dulic V., Kaufmann W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994, 76:1013-1023.
31. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
32. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer E., Givol D. Induction of Waf1/CIP1 by a p53-independent pathway. Cancer Res 1994, 54:3391-3395.
33. Macleod K.F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995, 9:935-944.
34. Meeran S.M., Katiyar S.K. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci. 2008, 13:2191-2202.
35. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
36. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178.
37. Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S., et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995, 182:1777-1783.
38. Fujita T., Maruyama M., Araya J., Sassa K., Kawagishi Y., Hayashi R., et al. Hydrogen peroxide induces upregulation of Fas in human airway epithelial cells via the activation of PARP-p53 pathway. Am J Respir Cell Mol Biol 2002, 27:542-552.
39. Serrao K.L., Fortenberry J.D., Owens M.L., Harris F.L., Brown L.A. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol 2001, 280:L298-L305.